Peripheral arterial chemoreceptors and sudden infant death syndrome

Estelle B Gauda1, Elizabeth Cristofalo, Jeanne Nunez

  • 1Department of Pediatrics, Division of Neonatology, Johns Hopkins Medical Institutions, Johns Hopkins Hospital, Baltimore, MD 21287-3200, USA. egauda@jhmi.edu

Insights

Sudden infant death syndrome (SIDS) risk is higher in premature infants. Impaired peripheral arterial chemoreceptors (PACs) may explain this increased SIDS risk in vulnerable infants.

Area of Science:

  • Neonatal physiology
  • Respiratory control
  • Sudden Infant Death Syndrome (SIDS) research

Background:

  • Sudden infant death syndrome (SIDS) is a leading cause of infant mortality, disproportionately affecting premature and low birth weight infants.
  • Premature infants face increased SIDS risk due to potential maladaptive responses in peripheral arterial chemoreceptors (PACs) following early-life oxygen stress.
  • PACs are crucial for mediating ventilation, arousal, and cardiorespiratory responses to hypoxia and airway obstruction, and are vulnerable to environmental influences during development.

Purpose of the Study:

  • To explore the potential role of peripheral arterial chemoreceptor (PAC) hypo- and hypersensitivity in the increased incidence of SIDS among premature infants.
  • To review the biological mechanisms linking PAC dysfunction to SIDS risk in at-risk infant populations.

Main Methods:

  • Review of existing epidemiological and physiological evidence.
  • Analysis of the role of PACs in cardiorespiratory control and arousal mechanisms.
  • Examination of the impact of early-life oxygen exposure on PAC development and function.

Main Results:

  • Premature infants exhibit a higher risk of SIDS, with a notable increase in the proportion of SIDS deaths attributed to this group.
  • Hypo- or hypersensitivity of PACs, potentially resulting from early-life oxygen stress, may impair arousal and cardiorespiratory responses to asphyxial events.
  • PAC dysfunction can negatively impact responses to laryngeal chemoreflex activation, which may be triggered by events like gastric reflux or infections.

Conclusions:

  • Peripheral arterial chemoreceptor (PAC) dysfunction (both hypo- and hypersensitivity) is a plausible biological mechanism contributing to the elevated SIDS risk in premature infants.
  • Environmental factors affecting PAC development in premature infants may predispose them to SIDS.
  • Further research into PAC function in premature infants is warranted to understand and potentially mitigate SIDS risk.

Related Concept Videos

Chemical Factors Affecting Respiration Centers01:31

Chemical Factors Affecting Respiration Centers

Chemical factors such as changing CO2, O2, and H+ levels in arterial blood play a critical role in influencing respiration depth and rates. These variations are detected by chemoreceptors—specialized sensors located in two primary body areas. Central chemoreceptors are found throughout the brain stem, including the ventrolateral medulla, while peripheral chemoreceptors are located in the aortic arch and carotid arteries.
CO2 has a potent influence on respiration and is strictly regulated. Under...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without causing...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include: